莫西沙星治疗社区获得性肺炎的临床效果观察

目的探讨莫西沙星治疗社区获得性肺炎的临床效果。方法 120例社区获得性肺炎者作为研究对象被随机分为实验组和对照组。对照组给予阿奇霉素治疗,实验组给予莫西沙星治疗。结果实验组显效率显著优于对照组（χ^2=6.065,P〈0.05）;总有效率优于对照组,但无显著性差异（χ^2=2.743,P〉0.05）;副反应率少于对照组,但无显著性差异（χ^2=0.093,P〉0.05）。结论莫西沙星治疗社区获得性肺炎具有更好的治疗效果,值得患者考虑。

The Clinical Effect of Moxifloxacin for the Treatment of Community Acquired Pneumonia

Objective To explore the clinical effect of moxifloxacin in treatment of patients with community acquired pneumonia （CAP）. Methods 120 cases of patients with community acquired pneumonia were randomly divided into the experimental group and control group. Azithromycin was used for the control group and moxifloxacin was used for the experimental group. Results The obvious effective rate of the experimental group was significantly higher than that of the control group （X^2 = 6.065, P 〈0.05）; the total effective rate of the experimental group was higher than that of the control group but had no significant difference （X^2 = 2.743, P〉0.05）; the side-reaction rate of the experimental group was higher than that of the control group but had no significant difference （X^2 = 0.093, P 〉0.05）. Conclusions Moxifloxacin has better clinical effect in treatment of patients with community acquired pneumonia, which is a good choice for patients.